In the BioHarmony Drug Report Database

"Preview" Icon

Trandolapril

Mavik (trandolapril) is a small molecule pharmaceutical. Trandolapril was first approved as Mavik on 1996-04-26. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against angiotensin-converting enzyme.

 

Trade Name

 

Mavik
 

Common Name

 

trandolapril
 

ChEMBL ID

 

CHEMBL1519
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Antihypertensives (ACE inhibitors)

Image (chem structure or protein)

Trandolapril structure rendering